|
FOR RELEASE ON |
07 September 2022 |
IP Group plc - SAYE Scheme; PDMR shareholding
IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), which develops world-changing science and technology businesses across life sciences, technology and cleantech, announces the following in connection with its employee share schemes.
SAVE AS YOU EARN ("SAYE") SHARESAVE PLAN
IP Group has granted options over the Company's ordinary shares of 2p each ("Shares"), under its SAYE Sharesave Plan to persons discharging managerial responsibilities ("PDMRs") of the Company as detailed below.
|
Name |
Plan duration |
Number of options granted |
|
Greg Smith |
3 years |
27,692 |
|
David Baynes |
3 years |
27,692 |
|
Angela Leach |
3 years |
11,076 |
|
Lisa Patel |
3 years |
22,153 |
|
Mark Reilly |
3 years |
16,615 |
|
Douglas Moray Wright |
3 years |
27,692 |
|
Anthony York |
3 years |
19,384 |
In addition to the above, options over a total of 439,796 Shares were granted to certain other employees of the Group under the Sharesave Plan.
All of the above SAYE options have been granted on 07 September 2022 at an exercise price of 65.0 pence per share, with the SAYE contracts commencing on 01 November 2022. The exercise price was set in accordance with HM Revenue & Customs rules for Sharesave plans.
Permitted exercise periods are for a period of six months from the end of the plan period, ordinarily 01 November 2025.
Shares in issue
At the date of this announcement, the Company continues to have 1,063,033,287 Shares in issue and 28,607,622 Shares held in treasury.
The following information is being disclosed pursuant to the requirements of MAR.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
SAYE Sharesave Plan
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
||||||||||||||||||||||||||||||||||
|
a) |
Name(s) |
Greg Smith David Baynes Angela Leach Lisa Patel Mark Reilly Douglas Moray Wright Anthony York |
|||||||||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||||||||
|
2 |
Reason for the notification |
||||||||||||||||||||||||||||||||||
|
a) |
Position/status |
Executive Director Chief Executive Officer Executive Director Chief Financial and Operating Officer PDMR Partner, Life Sciences PDMR Managing Partner, Technology PDMR CEO Parkwalk PDMR Group People Director |
|||||||||||||||||||||||||||||||||
|
|
Initial notification /Amendment |
Initial Notification |
|||||||||||||||||||||||||||||||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||||||||||||||||||||||||||||||||
|
a) |
Name |
IP Group plc |
|||||||||||||||||||||||||||||||||
|
b) |
Legal Entity Identifier |
213800HG22UM138WFG43 |
|||||||||||||||||||||||||||||||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||||||||||||||||||||||||||||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary Shares of 2p each in IP Group plc |
|||||||||||||||||||||||||||||||||
|
b) |
Nature of the transaction |
Conditional award of Shares under the IP Group plc SAYE Sharesave Plan |
|||||||||||||||||||||||||||||||||
|
c) |
Currency |
GBP |
|||||||||||||||||||||||||||||||||
|
d) |
Price(s) and volume(s) |
|
|||||||||||||||||||||||||||||||||
|
e) |
Aggregated information -Aggregated volume
- Price - Aggregated total |
Aggregated Number of Shares conditionally awarded under the SAYE Sharesave Plan to PDMRs on 07 September 2022: 152,304 Price: 65.0p |
|||||||||||||||||||||||||||||||||
|
f) |
Date of the transaction |
07 September 2022 |
|||||||||||||||||||||||||||||||||
|
g) |
Place of the transaction |
Outside a trading venue
|
|||||||||||||||||||||||||||||||||
For more information, please contact:
|
IP Group plc |
|
|
David Baynes, Chief Financial and Operating Officer |
+44 (0) 20 7444 0050 |
Notes for editors
About IP Group
IP Group develops world-changing science and technology businesses across life sciences, technology and cleantech (through Kiko Ventures). The Group has a strong track record of success, having been the founder investor in a number of high-profile companies including Oxford Nanopore Technologies plc, and has one of the most exciting portfolios of high-growth businesses in Europe. The Group also owns Parkwalk, the UK's largest growth EIS fund manager which backs world-changing technologies emerging from the UK's leading universities and research institutions. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.
For more information, please visit our website at www.ipgroupplc.com.
ENDS
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
